EVs from BALF-Mediators of Inflammation and Potential Biomarkers in Lung Diseases

被引:29
|
作者
Zareba, Lukasz [1 ]
Szymanski, Jacek [1 ,2 ]
Homoncik, Zuzanna [1 ]
Czystowska-Kuzmicz, Malgorzata [1 ]
机构
[1] Med Univ Warsaw, Chair & Dept Biochem, Banacha 1, PL-02097 Warsaw, Poland
[2] Warsaw Univ Technol, Fac Chem, Noakowskiego 3, PL-00664 Warsaw, Poland
关键词
extracellular vesicles (EVs); bronchoalveolar lavage fluid (BALF); inflammatory lung diseases; lung cancer; exosomes; biomarker;
D O I
10.3390/ijms22073651
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular vesicles (EVs) have been identified as key messengers of intracellular communication in health and disease, including the lung. EVs that can be found in bronchoalveolar lavage fluid (BALF) are released by multiple cells of the airways including bronchial epithelial cells, endothelial cells, alveolar macrophages, and other immune cells, and they have been shown to mediate proinflammatory signals in many inflammatory lung diseases. They transfer complex molecular cargo, including proteins, cytokines, lipids, and nucleic acids such as microRNA, between structural cells such as pulmonary epithelial cells and innate immune cells such as alveolar macrophages, shaping mutually their functions and affecting the alveolar microenvironment homeostasis. Here, we discuss this distinct molecular cargo of BALF-EVs in the context of inducing and propagating inflammatory responses in particular acute and chronic lung disorders. We present different identified cellular interactions in the inflammatory lung via EVs and their role in lung pathogenesis. We also summarize the latest studies on the potential use of BALF-EVs as diagnostic and prognostic biomarkers of lung diseases, especially of lung cancer.
引用
收藏
页数:26
相关论文
共 50 条
  • [21] Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?
    Pulito-Cueto, Veronica
    Remuzgo-Martinez, Sara
    Genre, Fernanda
    Atienza-Mateo, Belen
    Mora-Cuesta, Victor M.
    Iturbe-Fernandez, David
    Lera-Gomez, Leticia
    Rodriguez-Carrio, Javier
    Prieto-Pena, Diana
    Portilla, Virginia
    Blanco, Ricardo
    Corrales, Alfonso
    Gualillo, Oreste
    Cifrian, Jose M.
    Lopez-Mejias, Raquel
    Gonzalez-Gay, Miguel A.
    BIOMEDICINES, 2022, 10 (04)
  • [22] Endothelial Cell-Derived Extracellular Vesicles as Potential Biomarkers in Chronic Interstitial Lung Diseases
    Neri, Tommaso
    Tavanti, Laura
    De Magistris, Sara
    Lombardi, Stefania
    Romei, Chiara
    Falaschi, Fabio
    Paggiaro, Pierluigi
    Celi, Alessandro
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2019, 49 (05): : 608 - 610
  • [23] From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases
    Sarb, Oliviu-Florentiu
    Sarb, Adriana-Daniela
    Iacobescu, Maria
    Vlad, Irina-Maria
    Milaciu, Mircea-Vasile
    Ciurmarnean, Lorena
    Vacaras, Vitalie
    Tantau, Alina-Ioana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [24] The Therapeutic Potential of Differentiated Lung Cells from Embryonic Stem Cells in Lung Diseases
    Dezfouli, Mohammad Reza Mokhber
    Chaleshtori, Sirous Sadeghian
    Dehghan, Mohammad Mehdi
    Tavanaeimanesh, Hamid
    Baharvand, Hossein
    Tahamtani, Yaser
    CURRENT STEM CELL RESEARCH & THERAPY, 2017, 12 (01) : 80 - 84
  • [25] An efficient hybrid feature selection method to identify potential biomarkers in common chronic lung inflammatory diseases
    Maghsoudloo, Mazaher
    Jamalkandi, Sadegh Azimzadeh
    Najafi, Ali
    Masoudi-Nejad, Ali
    GENOMICS, 2020, 112 (05) : 3284 - 3293
  • [26] Novel Biomarkers in Lung Cancer and Chronic Lung Diseases: From the Systematic Perspective of Yin-Yang Balance
    Jeong, Mi-Kyung
    Chun, Jaemoo
    Oh, In-Jae
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [27] From pre-clinical data to the clinics: identification of circulating inflammatory mediators as potential biomarkers for heart failure
    Altara, Raffaele
    FASEB JOURNAL, 2014, 28 (01):
  • [28] Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases
    d'Alessandro, Miriana
    De Vita, Elda
    Bergantini, Laura
    Mazzei, Maria Antonietta
    di Valvasone, Simona
    Bonizzoli, Manuela
    Peris, Adriano
    Sestini, Piersante
    Bargagli, Elena
    Bennett, David
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2020, 282
  • [29] Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases
    Peng Zhou
    Fang Hua
    Xiang Wang
    Jin-Ling Huang
    Inflammopharmacology, 2020, 28 : 19 - 37
  • [30] Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases
    Zhou, Peng
    Hua, Fang
    Wang, Xiang
    Huang, Jin-Ling
    INFLAMMOPHARMACOLOGY, 2020, 28 (01) : 19 - 37